EFPIA

News

Pharma says EU chemical ban could devastate manufacturing

A trade organisation representing pharma manufacturers in Europe has said plans to restrict the use of fluorinated substances known as PFAS could make manufacturing “grind

News

Pharma incensed by EU's compulsory licensing proposal

Pharma industry bodies have slammed a proposal by the European Commission to set up a compulsory licensing (CL) framework for medicines in emergency situations, claiming t

News

Rare Disease Moonshot launched at European Health Summit

A new initiative to boost research and development into rare and paediatric diseases launched last week, on Thursday 8th December, at the European Health Summit.

Views & Analysis

New IFPMA and EFPIA guidance on use of social media by the p...

On 28 September 2022, the international and European self-regulatory bodies for the research-based pharmaceutical industry (I

Market Access

Are timely access and robust safety mutually exclusive?

The FDA approves new cancer treatments in half the time of the EMA – but does faster mean better? And how can regulators balance timely access with robust safety?

Digital